Phase II trial of bicalutamide in patients with advanced prostate cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235)

This publication has 13 references indexed in Scilit:

• Measuring change over time: Assessing the usefulness of evaluative instruments
  Published by Elsevier ,2004
• Symptom distress, current concerns and mood disturbance after diagnosis of life-threatening disease
  Published by Elsevier ,2002
• HIGH DOSE BICALUTAMIDE FOR ANDROGEN INDEPENDENT PROSTATE CANCER: EFFECT OF PRIOR HORMONAL THERAPY
  Journal of Urology, 1998
• Bicalutamide for advanced prostate cancer: the natural versus treated history of disease.
  Journal of Clinical Oncology, 1997
• Combined androgen blockade for the treatment of metastatic cancer of the prostate
  Urology, 1996
• Hormone-refractory (D3) prostate cancer: Refining the concept
  Urology, 1995
• Quality of life in prostate cancer
  The Prostate, 1992
• Effect Sizes for Interpreting Changes in Health Status
  Medical Care, 1989
• The measurement of symptom distress
  Seminars in Oncology Nursing, 1987
• The short-form McGill pain questionnaire
  Pain, 1987